September 14, 2021
Kyowa Kirin said on September 13 that it has commenced a Japanese PII clinical study of G-Lasta (pegfilgrastim), a sustained-release granulocyte colony-stimulating factor (G-CSF) preparation, for the mobilization of hematopoietic stem cells into peripheral blood for autologous blood stem cell...read more